A new enzyme-based molecular design with key implications in radiotheranostics (IMAGE)
Caption
1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-based reagents, when conjugated to antibody fragments and injected into mice, produced the metabolites [111In]In-DO3AiBu-Bn-F and [111In]In-DOTA-Bn-F, which were dissimilarly eliminated by the kidneys. Quite notably, [111In]In-DO3AiBu-Bn-FGK-Fab showed the lowest renal localization without impairing tumor accumulation, thus paving the way for the possible clinical evaluation of this radiotheranostic approach.
Credit
Suzuki et al., Chiba University
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.
License
CC BY-NC-ND